24th Jan 2006 16:00
AstraZeneca PLC24 January 2006 Dealing by Directors Companies Act 1985 Sections 324/329 Transaction by Persons Discharging Managerial Responsibilities Disclosure Rules DR 3.1.2R We hereby inform you that, on 23 January 2006, Dr H L Mogren, a Director of theCompany, ceased to have an interest in an option over 9,826 AstraZeneca PLCOrdinary Shares of USD0.25 each following its expiry. The option was originally granted to Dr Mogren in 1999 for a period of sevenyears over shares in Astra AB under the Astra Shareholder Value Incentive Plan.The option was subsequently converted into an option over Ordinary Shares inAstraZeneca PLC in April 1999. The option has not been exercised by Dr Mogrenand has consequently expired on reaching the seventh anniversary of the date ofgrant. Details of the option are as follows:- Number of AstraZeneca shares over which Effective option Market price of AstraZeneca sharesoption was held price per share when option expired 9,826 441.78SEK 356.50SEK Following the expiry of this option, Dr Mogren holds options over 244,896Ordinary Shares of AstraZeneca PLC. G H R Musker Company Secretary 24 January 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca